Matches in Wikidata for { <http://www.wikidata.org/entity/Q65541149> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q65541149 description "clinical trial" @default.
- Q65541149 description "ensayu clínicu" @default.
- Q65541149 description "klinisch onderzoek" @default.
- Q65541149 description "клінічне випробування" @default.
- Q65541149 description "կլինիկական փորձարկում" @default.
- Q65541149 name "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 name "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 type Item @default.
- Q65541149 label "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 label "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 prefLabel "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 prefLabel "Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia" @default.
- Q65541149 P1050 Q65541149-4FBC0F99-42E0-409A-8634-D054147EAE40 @default.
- Q65541149 P1132 Q65541149-C47D3713-D4DE-454C-A8AF-03F98457E02E @default.
- Q65541149 P1476 Q65541149-9FDDC620-1A7E-4267-B713-196015CAE9CD @default.
- Q65541149 P17 Q65541149-097C1FB8-3839-4137-846E-5E7BEE56986B @default.
- Q65541149 P17 Q65541149-22FDF853-F691-46DA-9EF0-D089D4A1CBB1 @default.
- Q65541149 P17 Q65541149-5E93B240-4B34-4894-97AE-242D8AEB1F9F @default.
- Q65541149 P17 Q65541149-85AE4665-1761-4E92-907E-2924A9001C10 @default.
- Q65541149 P17 Q65541149-8F941221-EE14-4B3B-B881-FF85C2CEB3B6 @default.
- Q65541149 P17 Q65541149-A0A031EC-510E-479C-872A-01BA469E55A5 @default.
- Q65541149 P17 Q65541149-AF768DEB-23A6-4A6A-A5A7-6720448B509E @default.
- Q65541149 P17 Q65541149-D9A8EDC1-27B1-4BE0-B12D-6C8651F38ED8 @default.
- Q65541149 P2899 Q65541149-CABBD239-B3A5-4B58-BAAA-24D1899729C0 @default.
- Q65541149 P3098 Q65541149-B533493F-CA8C-4FA3-A5B9-0E95C96FE18F @default.
- Q65541149 P31 Q65541149-37ED9375-FD45-46C9-B681-07689E036243 @default.
- Q65541149 P4135 Q65541149-56874BC9-EC82-4F61-AEC5-BA53605C251D @default.
- Q65541149 P580 Q65541149-D0B94DFE-16AB-49AF-A401-68A07F991A36 @default.
- Q65541149 P582 Q65541149-0F921287-A511-4BD4-97A1-C8583231EB13 @default.
- Q65541149 P6099 Q65541149-99E10C81-3DBC-444A-8664-542ED179353B @default.
- Q65541149 P6153 Q65541149-B00E2ABB-2835-43DF-9FAD-4D960FC9A2AC @default.
- Q65541149 P8363 Q65541149-3038F423-5B15-4280-9E23-F70949635058 @default.
- Q65541149 P1050 Q41112 @default.
- Q65541149 P1132 "+221" @default.
- Q65541149 P1476 "26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia" @default.
- Q65541149 P17 Q212 @default.
- Q65541149 P17 Q30 @default.
- Q65541149 P17 Q334 @default.
- Q65541149 P17 Q419 @default.
- Q65541149 P17 Q668 @default.
- Q65541149 P17 Q739 @default.
- Q65541149 P17 Q800 @default.
- Q65541149 P17 Q833 @default.
- Q65541149 P2899 "+13" @default.
- Q65541149 P3098 "NCT00265382" @default.
- Q65541149 P31 Q30612 @default.
- Q65541149 P4135 "+17" @default.
- Q65541149 P580 "2006-06-01T00:00:00Z" @default.
- Q65541149 P582 "2009-06-01T00:00:00Z" @default.
- Q65541149 P6099 Q42824827 @default.
- Q65541149 P6153 Q206921 @default.
- Q65541149 P8363 Q78089383 @default.